The gains in the global fight against tuberculosis have been threatened as a result of the COVID-19 pandemic, including a diversion of resources that have led to disruptions in ongoing research and control programs.
MeiLan K. Han, MD, and Paul Enright, MD, share their opposing perspectives on the necessity and utility of defining “pre-COPD” in at-risk patients.
Mask-related side effects have been cited as the most important factor influencing adherence to continuous positive airway pressure (CPAP) therapy.
Consumer e-cigarette use has reversed some of the gains in public health efforts against smoking and increased rates of nicotine consumption.
Along with a wide range of elective medical services affected by the COVID-19 crisis, pulmonary screenings decreased substantially, especially in the early months of the pandemic.
In part 3 of this series, we interviewed Samuel Cykert, MD, who helped build a system-based intervention to reduce racial gaps and improve care for all patients with lung cancer.
In part 2 of this 3-part series, the recent State of Lung Cancer report by the American Lung Association, which included state-level and national-level data on lung cancer in people of color for the first time.
A sizable body of research has long shown racial disparities in treatment and survival between Black and White patients with lung cancer.
The National Asthma Education and Prevention Program published focused updates to their asthma management guidelines.
A growing number of studies involve the role of prone positioning to improve ventilation in patients with acute respiratory distress syndrome (ARDS) related to COVID-19.
